Mixture of Antibody Arrays to Functionally Characterize Darkish Proteins in Human Olfactory Neuroepithelial Cells
The completion and annotation of the human proteome require the provision of knowledge associated to protein perform. Presently, greater than 1800 human genes represent the “darkish proteome,” which embody lacking proteins, uncharacterized human genes validated at protein degree, smORFs, proteins from lncRNAs, or any uncharacterized transcripts. Over the past years, totally different experimental workflows primarily based on multi-omics analyses, bioinformatics, and in vitro and in vivo research have been promoted by the Human Proteome Challenge Consortium to boost the annotation of darkish proteins.
On this chapter, we describe a technique that makes use of recombinant proteins and antibody arrays to ascertain an easy methodology in an effort to quickly characterize potential practical options of darkish proteins related to intracellular signaling dynamics and extracellular immune response in human cell cultures. Additional validating the strategy, this workflow was utilized to probe adjustments within the activation patterns of kinases and transcription components in addition to in cytokine manufacturing modulated by the darkish C1orf128 (PITHD1) protein in human olfactory neuroepithelial cells.
Identification of Antibody Biomarker Utilizing Excessive-Density Nucleic Acid Programmable Protein Array
A novel protein microarray expertise, known as high-density nucleic acid programmable protein array (HD-NAPPA), allows the serological screening of hundreds of proteins at one time. HD-NAPPA extends the capabilities of NAPPA, which produces protein microarrays on a standard glass microscope slide. By comparability, HD-NAPPA shows proteins in over 10,000 nanowells etched in a silicon slide.
Proteins on HD-NAPPA are expressed within the particular person remoted nanowells, through in vitro transcription and translation (IVTT), with none diffusion throughout incubation. Right here we describe the strategy for antibody biomarker identification utilizing HD-NAPPA, together with 4 major steps: (1) HD-NAPPA array protein expression, (2) main antibodies (serum/plasma) probing, (3) secondary antibody visualization, and (4) picture scanning and information processing.
SUFU Antibody |
|||
1-CSB-PA022923GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against SUFU. Recognizes SUFU from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC |
SUFU Antibody |
|||
DF7687 | Affbiotech | 200ul | EUR 420 |
SUFU Antibody |
|||
DF7687-100ul | Affinity Biosciences | 100ul | EUR 280 |
SUFU Antibody |
|||
DF7687-200ul | Affinity Biosciences | 200ul | EUR 350 |
SUFU antibody |
|||
E39-08373 | EnoGene | 100ug/100ul | EUR 225 |
Description: Available in various conjugation types. |
SUFU antibody |
|||
E39-10794 | EnoGene | 100ug/100ul | EUR 225 |
Description: Available in various conjugation types. |
sufu Antibody |
|||
E93273 | EnoGene | 100ul | EUR 255 |
Description: Available in various conjugation types. |
SUFU Antibody |
|||
E309471 | EnoGene | 200ul | EUR 275 |
Description: Available in various conjugation types. |
SUFU antibody |
|||
70R-20639 | Fitzgerald | 50 ul | EUR 289 |
Description: Rabbit polyclonal SUFU antibody |
SUFU Antibody |
|||
ABD7687 | Nova Lifetech | 100ug | EUR 325 |
SUFU Antibody |
|||
ABD7828 | Nova Lifetech | 100ug | EUR 325 |
SUFU Antibody |
|||
GWB-ML480C | GenWay Biotech | 50ug | Ask for price |
SUFU Antibody |
|||
GWB-ML481D | GenWay Biotech | 50ug | Ask for price |
SUFU Antibody |
|||
GWB-MN004D | GenWay Biotech | 50ug | Ask for price |
SUFU Antibody |
|||
MBS7124473-005mL | MyBiosource | 0.05mL | EUR 190 |
SUFU Antibody |
|||
MBS7124473-01mL | MyBiosource | 0.1mL | EUR 270 |
SUFU Antibody |
|||
MBS7124473-5x01mL | MyBiosource | 5x0.1mL | EUR 1205 |
SUFU antibody |
|||
MBS9414663-005mL | MyBiosource | 0.05mL | EUR 300 |
SUFU antibody |
|||
MBS9414663-01mL | MyBiosource | 0.1mL | EUR 390 |
SUFU antibody |
|||
MBS9414663-5x01mL | MyBiosource | 5x0.1mL | EUR 1610 |
SUFU Antibody |
|||
MBS9405216-01mL | MyBiosource | 0.1mL | EUR 305 |
SUFU Antibody |
|||
MBS9405216-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
SUFU Antibody |
|||
MBS9230955-005mL | MyBiosource | 0.05mL | EUR 210 |
SUFU Antibody |
|||
MBS9230955-02mL | MyBiosource | 0.2mL | EUR 430 |
SUFU Antibody |
|||
MBS9230955-5x02mL | MyBiosource | 5x0.2mL | EUR 1910 |
sufu Antibody |
|||
MBS8505037-01mL | MyBiosource | 0.1mL | EUR 325 |
sufu Antibody |
|||
MBS8505037-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
sufu Antibody |
|||
MBS8505037-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
sufu Antibody |
|||
MBS8505037-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
sufu Antibody |
|||
MBS8505037-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
SUFU Antibody |
|||
MBS8517065-005mg | MyBiosource | 0.05mg | EUR 235 |
SUFU Antibody |
|||
MBS8517065-01mg | MyBiosource | 0.1mg | EUR 305 |
SUFU Antibody |
|||
MBS8517065-01mLAF405M | MyBiosource | 0.1mL(AF405M) | EUR 465 |
SUFU Antibody |
|||
MBS8517065-01mLAF546 | MyBiosource | 0.1mL(AF546) | EUR 465 |
SUFU Antibody |
|||
MBS8517065-01mLAF750 | MyBiosource | 0.1mL(AF750) | EUR 465 |
Sufu antibody |
|||
MBS5309640-005mg | MyBiosource | 0.05mg | EUR 485 |
Sufu antibody |
|||
MBS5309640-5x005mg | MyBiosource | 5x0.05mg | EUR 2045 |
SUFU Antibody |
|||
MBS9608269-01mL | MyBiosource | 0.1mL | EUR 260 |
SUFU Antibody |
|||
MBS9608269-02mL | MyBiosource | 0.2mL | EUR 305 |
SUFU Antibody |
|||
MBS9608269-5x02mL | MyBiosource | 5x0.2mL | EUR 1220 |
anti- SUFU antibody |
|||
FNab08373 | FN Test | 100µg | EUR 658.5 |
Description: Antibody raised against SUFU |
SUFU Negative Regulator of Hedgehog Signaling (SUFU) Antibody |
|||
20-abx127058 | Abbexa |
|
|
SUFU Negative Regulator of Hedgehog Signaling (SUFU) Antibody |
|||
abx145714-100ug | Abbexa | 100 ug | EUR 469.2 |
SUFU Negative Regulator of Hedgehog Signaling (SUFU) Antibody |
|||
20-abx141906 | Abbexa |
|
|
SUFU Negative Regulator of Hedgehog Signaling (SUFU) Antibody |
|||
20-abx005181 | Abbexa |
|
|
SUFU Negative Regulator Of Hedgehog Signaling (SUFU) Antibody |
|||
20-abx211712 | Abbexa |
|
|
SUFU Negative Regulator of Hedgehog Signaling (SUFU) Antibody |
|||
abx238373-100ug | Abbexa | 100 ug | EUR 610.8 |
SUFU Negative Regulator of Hedgehog Signaling (SUFU) Antibody |
|||
20-abx322260 | Abbexa |
|
|
SUFU Negative Regulator Of Hedgehog Signaling (SUFU) Antibody |
|||
abx211712-100l | Abbexa | 100 µl | EUR 350 |
SUFU Negative Regulator Of Hedgehog Signaling (SUFU) Antibody |
|||
abx211712-50l | Abbexa | 50 µl | EUR 250 |
SUFU Negative Regulator of Hedgehog Signaling (SUFU) Antibody |
|||
abx238373-100g | Abbexa | 100 µg | EUR 350 |
SUFU Negative Regulator of Hedgehog Signaling (SUFU) Antibody |
|||
abx145714-1096tests | Abbexa | 10 × 96 tests | Ask for price |
SUFU Negative Regulator of Hedgehog Signaling (SUFU) Antibody |
|||
abx145714-596tests | Abbexa | 5 × 96 tests | Ask for price |
SUFU Negative Regulator of Hedgehog Signaling (SUFU) Antibody |
|||
abx145714-96tests | Abbexa | 96 tests | EUR 337.5 |
SUFU Negative Regulator of Hedgehog Signaling (SUFU) Antibody |
|||
abx218817-100tests | Abbexa | 100 tests | Ask for price |
SUFU Negative Regulator of Hedgehog Signaling (SUFU) Antibody |
|||
abx218817-200tests | Abbexa | 200 tests | Ask for price |
SUFU Negative Regulator of Hedgehog Signaling (SUFU) Antibody |
|||
abx218817-20tests | Abbexa | 20 tests | EUR 350 |
SUFU Negative Regulator of Hedgehog Signaling (SUFU) Antibody |
|||
abx433613-100g | Abbexa | 100 µg | EUR 387.5 |
SUFU Negative Regulator of Hedgehog Signaling (SUFU) Antibody |
|||
abx322260-100g | Abbexa | 100 µg | EUR 350 |
SUFU Negative Regulator of Hedgehog Signaling (SUFU) Antibody |
|||
abx322260-50g | Abbexa | 50 µg | EUR 237.5 |
SUFU Negative Regulator of Hedgehog Signaling (SUFU) Antibody |
|||
abx005181-100l | Abbexa | 100 µl | EUR 400 |
SUFU Negative Regulator of Hedgehog Signaling (SUFU) Antibody |
|||
abx005181-20l | Abbexa | 20 µl | EUR 175 |
SUFU Negative Regulator of Hedgehog Signaling (SUFU) Antibody |
|||
abx005181-50l | Abbexa | 50 µl | EUR 275 |
SUFU Antibody (C-term) |
|||
MBS9215763-005mL | MyBiosource | 0.05mL | EUR 210 |
SUFU Antibody (C-term) |
|||
MBS9215763-02mL | MyBiosource | 0.2mL | EUR 430 |
SUFU Antibody (C-term) |
|||
MBS9215763-5x02mL | MyBiosource | 5x0.2mL | EUR 1910 |
SUFU antibody - middle region |
|||
MBS3201285-01mL | MyBiosource | 0.1mL | EUR 455 |
SUFU antibody - middle region |
|||
MBS3201285-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
SUFU antibody - middle region |
|||
MBS3204508-01mL | MyBiosource | 0.1mL | EUR 455 |
SUFU antibody - middle region |
|||
MBS3204508-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
SUFU Antibody - middle region |
|||
MBS3223163-01mL | MyBiosource | 0.1mL | EUR 455 |
SUFU Antibody - middle region |
|||
MBS3223163-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
SUFU Antibody - middle region |
|||
MBS3223164-01mL | MyBiosource | 0.1mL | EUR 455 |
SUFU Antibody - middle region |
|||
MBS3223164-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
OACA07036-50UL - SUFU Antibody |
|||
OACA07036-50UL | Aviva Systems Biology | 50ul | EUR 189 |
OAAN01995-50UL - SUFU Antibody |
|||
OAAN01995-50UL | Aviva Systems Biology | 50ul | EUR 149 |
OACA07036-100UL - SUFU Antibody |
|||
OACA07036-100UL | Aviva Systems Biology | 100ul | EUR 230 |
OAAN01995-100UL - SUFU Antibody |
|||
OAAN01995-100UL | Aviva Systems Biology | 100ul | EUR 249 |
OAAN01995-200UL - SUFU Antibody |
|||
OAAN01995-200UL | Aviva Systems Biology | 200ul | EUR 389 |
OAAL00696-100UG - SUFU Antibody |
|||
OAAL00696-100UG | Aviva Systems Biology | 100ug | EUR 349 |
OAGA04566-100UL - SUFU Antibody |
|||
OAGA04566-100UL | Aviva Systems Biology | 100ul | EUR 369 |
SUFU (pS342) Antibody |
|||
20-abx000504 | Abbexa |
|
|
SUFU Polyclonal Antibody |
|||
E96757 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
SUFU Polyclonal Antibody |
|||
E913429 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
SUFU Conjugated Antibody |
|||
C39155 | SAB | 100ul | EUR 476.4 |
SUFU Conjugated Antibody |
|||
C35993 | SAB | 100ul | EUR 476.4 |
SUFU Polyclonal Antibody |
|||
MBS129948-002mL | MyBiosource | 0.02mL | EUR 190 |
SUFU Polyclonal Antibody |
|||
MBS129948-005mL | MyBiosource | 0.05mL | EUR 235 |
SUFU Polyclonal Antibody |
|||
MBS129948-01mL | MyBiosource | 0.1mL | EUR 320 |
SUFU Polyclonal Antibody |
|||
MBS129948-02mL | MyBiosource | 0.2mL | EUR 500 |
SUFU Polyclonal Antibody |
|||
MBS129948-5x02mL | MyBiosource | 5x0.2mL | EUR 2065 |
SUFU Polyclonal Antibody |
|||
MBS9133470-002mL | MyBiosource | 0.02mL | EUR 200 |
SUFU Polyclonal Antibody |
|||
MBS9133470-005mL | MyBiosource | 0.05mL | EUR 255 |
SUFU Polyclonal Antibody |
|||
MBS9133470-01mL | MyBiosource | 0.1mL | EUR 345 |
SUFU Polyclonal Antibody |
|||
MBS9133470-02mL | MyBiosource | 0.2mL | EUR 545 |
SUFU Polyclonal Antibody |
|||
MBS9133470-5x02mL | MyBiosource | 5x0.2mL | EUR 2265 |
SUFU Polyclonal Antibody |
|||
MBS8573078-01mL | MyBiosource | 0.1mL | EUR 305 |
SUFU Polyclonal Antibody |
|||
MBS8573078-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
SUFU Polyclonal Antibody |
|||
MBS8573078-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
SUFU Polyclonal Antibody |
|||
MBS8573078-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
SUFU Polyclonal Antibody |
|||
MBS8573078-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
SUFU Polyclonal Antibody |
|||
MBS8568160-01mL | MyBiosource | 0.1mL | EUR 305 |
SUFU Polyclonal Antibody |
|||
MBS8568160-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
SUFU Polyclonal Antibody |
|||
MBS8568160-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
SUFU Polyclonal Antibody |
|||
MBS8568160-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
SUFU Polyclonal Antibody |
|||
MBS8568160-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
SUFU Polyclonal Antibody |
|||
MBS2555007-006mL | MyBiosource | 0.06mL | EUR 190 |
SUFU Polyclonal Antibody |
|||
MBS2555007-012mL | MyBiosource | 0.12mL | EUR 265 |
SUFU Polyclonal Antibody |
|||
MBS2555007-02mL | MyBiosource | 0.2mL | EUR 415 |
SUFU Polyclonal Antibody |
|||
MBS2555007-5x02mL | MyBiosource | 5x0.2mL | EUR 1835 |
SUFU Conjugated Antibody |
|||
MBS9446456-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
SUFU Conjugated Antibody |
|||
MBS9446456-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
SUFU Conjugated Antibody |
|||
MBS9446456-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
SUFU Conjugated Antibody |
|||
MBS9446456-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
SUFU Conjugated Antibody |
|||
MBS9446456-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
SUFU Conjugated Antibody |
|||
MBS9449197-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
SUFU Conjugated Antibody |
|||
MBS9449197-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
SUFU Conjugated Antibody |
|||
MBS9449197-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
SUFU Conjugated Antibody |
|||
MBS9449197-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
SUFU Conjugated Antibody |
|||
MBS9449197-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
SUFU Polyclonal Antibody |
|||
RD81405A-120uL | Reddot Biotech | 120μL | EUR 360 |
Description: The Hedgehog signaling pathway plays an important role in early human development. The pathway is a signaling cascade that plays a role in pattern formation and cellular proliferation during development. This gene encodes a negative regulator of the hedgehog signaling pathway. Defects in this gene are a cause of medulloblastoma. Alternative splicing results in multiple transcript variants. |
SUFU Polyclonal Antibody |
|||
RD81405A-200uL | Reddot Biotech | 200μL | EUR 630 |
Description: The Hedgehog signaling pathway plays an important role in early human development. The pathway is a signaling cascade that plays a role in pattern formation and cellular proliferation during development. This gene encodes a negative regulator of the hedgehog signaling pathway. Defects in this gene are a cause of medulloblastoma. Alternative splicing results in multiple transcript variants. |
SUFU Polyclonal Antibody |
|||
RD81405A-60uL | Reddot Biotech | 60μL | EUR 204 |
Description: The Hedgehog signaling pathway plays an important role in early human development. The pathway is a signaling cascade that plays a role in pattern formation and cellular proliferation during development. This gene encodes a negative regulator of the hedgehog signaling pathway. Defects in this gene are a cause of medulloblastoma. Alternative splicing results in multiple transcript variants. |
Human, Rat, Mouse SUFU antibody |
|||
P0696 | Omnimabs | 100ul | EUR 150 |
Suppressor of Fused (SUFU) Antibody |
|||
E8RT1600 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
Polyclonal SUFU Antibody (C-term) |
|||
APR04889G | Leading Biology | 0.1ml | EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SUFU (C-term). This antibody is tested and proven to work in the following applications: |
SUFU antibody - N-terminal region |
|||
MBS3201286-01mL | MyBiosource | 0.1mL | EUR 455 |
SUFU antibody - N-terminal region |
|||
MBS3201286-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
Monoclonal SUFU Antibody, Clone: 1783CT536.263.29 |
|||
AMM02579G | Leading Biology | 0.1ml | EUR 580.8 |
Description: A Monoclonal antibody against Human SUFU. The antibodies are raised in Mouse and are from clone 1783CT536.263.29. This antibody is applicable in WB, E |
Polyclonal SUFU antibody - middle region |
|||
APR00655G | Leading Biology | 0.05mg | EUR 633.6 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SUFU - middle region. This antibody is tested and proven to work in the following applications: |
Polyclonal SUFU antibody - middle region |
|||
APR00749G | Leading Biology | 0.05mg | EUR 633.6 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SUFU - middle region. This antibody is tested and proven to work in the following applications: |
Sufu (Phospho-Ser342) Antibody |
|||
11552 | SAB | 100ul | EUR 319 |
Sufu (Phospho-Ser342) Antibody |
|||
11552-100ul | SAB | 100ul | EUR 302.4 |
Sufu (Phospho-Ser342) Antibody |
|||
11552-50ul | SAB | 50ul | EUR 224.4 |
Sufu (Phospho-Ser342) Antibody |
|||
E011552 | EnoGene | 100μg/100μl | EUR 225 |
Description: Available in various conjugation types. |
SUFU (Phospho-Ser346) Antibody |
|||
SAB260P | SAB | 100ul | EUR 319 |
SUFU Mouse Monoclonal Antibody |
|||
E10G34348 | EnoGene | 100 μl | EUR 275 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
Sufu (Phospho-Ser342) Antibody |
|||
MBS9403378-005mL | MyBiosource | 0.05mL | EUR 245 |
Sufu (Phospho-Ser342) Antibody |
|||
MBS9403378-01mL | MyBiosource | 0.1mL | EUR 305 |
Sufu (Phospho-Ser342) Antibody |
|||
MBS9403378-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
SUFU (Phospho-Ser346) Antibody |
|||
MBS9458452-005mL | MyBiosource | 0.05mL | EUR 245 |
SUFU (Phospho-Ser346) Antibody |
|||
MBS9458452-01mL | MyBiosource | 0.1mL | EUR 305 |
SUFU (Phospho-Ser346) Antibody |
|||
MBS9458452-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
SUFU Rabbit Polyclonal Antibody |
|||
E10G00795 | EnoGene | 100 μl | EUR 275 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
Polyclonal SUFU antibody - N-terminal region |
|||
APR00623G | Leading Biology | 0.05mg | EUR 633.6 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SUFU - N-terminal region. This antibody is tested and proven to work in the following applications: |
ARP39233_P050-25UL - SUFU Antibody - middle region |
|||
ARP39233_P050-25UL | Aviva Systems Biology | 25ul | EUR 99 |
ARP33018_P050-25UL - SUFU Antibody - middle region |
|||
ARP33018_P050-25UL | Aviva Systems Biology | 25ul | EUR 99 |
ARP87204_P050-25UL - SUFU Antibody - middle region |
|||
ARP87204_P050-25UL | Aviva Systems Biology | 25ul | EUR 99 |
ARP87205_P050-25UL - SUFU Antibody - middle region |
|||
ARP87205_P050-25UL | Aviva Systems Biology | 25ul | EUR 99 |
ARP39233_P050 - SUFU antibody - middle region (ARP39233_P050) |
|||
ARP39233_P050 | Aviva Systems Biology | 100ul | EUR 389 |
ARP33018_P050 - SUFU antibody - middle region (ARP33018_P050) |
|||
ARP33018_P050 | Aviva Systems Biology | 100ul | EUR 389 |
ARP87204_P050 - SUFU Antibody - middle region (ARP87204_P050) |
|||
ARP87204_P050 | Aviva Systems Biology | 100ul | EUR 389 |
ARP87205_P050 - SUFU Antibody - middle region (ARP87205_P050) |
|||
ARP87205_P050 | Aviva Systems Biology | 100ul | EUR 389 |
SUFU Negative Regulator Of Hedgehog Signaling Phospho-Ser342 (SUFU pS342) Antibody |
|||
abx332917-100ul | Abbexa | 100 ul | EUR 560.4 |
SUFU Negative Regulator Of Hedgehog Signaling Phospho-Ser342 (SUFU pS342) Antibody |
|||
abx332917-100g | Abbexa | 100 µg | Ask for price |
SUFU Negative Regulator Of Hedgehog Signaling Phospho-Ser342 (SUFU pS342) Antibody |
|||
abx332917-20g | Abbexa | 20 µg | EUR 412.5 |
SUFU Negative Regulator Of Hedgehog Signaling Phospho-Ser342 (SUFU pS342) Antibody |
|||
abx332917-50g | Abbexa | 50 µg | Ask for price |
Monoclonal SUFU Antibody (monoclonal) (M01), Clone: 1B2 |
|||
AMM04155G | Leading Biology | 0.1mg | EUR 580.8 |
Description: A Monoclonal antibody against Human SUFU (monoclonal) (M01). The antibodies are raised in Mouse and are from clone 1B2. This antibody is applicable in E |
ARP33019_P050-25UL - SUFU Antibody - N-terminal region |
|||
ARP33019_P050-25UL | Aviva Systems Biology | 25ul | EUR 99 |
SUFU Rabbit anti-Human Polyclonal Antibody |
|||
MBS2402439-005mL | MyBiosource | 0.05mL | EUR 615 |
SUFU Rabbit anti-Human Polyclonal Antibody |
|||
MBS2402439-5x005mL | MyBiosource | 5x0.05mL | EUR 2605 |
SUFU |
|||
E8ER1802-68 | EnoGene | 100ul | EUR 275 |
Description: Available in various conjugation types. |
SUFU |
|||
CSB-CL891560HU | Cusabio | 10 μg plasmid + 200μl Glycerol | Ask for price |
SUFU |
|||
pro-938 | ProSpec Tany | 5µg | EUR 60 |
Description: Recombinant Human Suppressor of Fused Homolog |
SUFU |
|||
MBS8565358-01mL | MyBiosource | 0.1mL | EUR 345 |
SUFU |
|||
MBS8565358-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
SUFU |
|||
MBS8565358-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
SUFU |
|||
MBS8565358-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
SUFU |
|||
MBS8565358-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
SUFU |
|||
MBS8561830-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
SUFU |
|||
MBS8561830-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
SUFU |
|||
MBS8561830-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
SUFU |
|||
MBS8561830-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
SUFU |
|||
MBS8561830-02mL | MyBiosource | 0.2mL | EUR 345 |
Sufu (Phospho-Ser342) Polyclonal Conjugated Antibody |
|||
C11552 | SAB | 100ul | EUR 476.4 |
Sufu (Phospho-Ser342) Polyclonal Conjugated Antibody |
|||
MBS9437166-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
Sufu (Phospho-Ser342) Polyclonal Conjugated Antibody |
|||
MBS9437166-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
Sufu (Phospho-Ser342) Polyclonal Conjugated Antibody |
|||
MBS9437166-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
Sufu (Phospho-Ser342) Polyclonal Conjugated Antibody |
|||
MBS9437166-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
Sufu (Phospho-Ser342) Polyclonal Conjugated Antibody |
|||
MBS9437166-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
SUFU siRNA |
|||
20-abx935622 | Abbexa |
|
|
SUFU siRNA |
|||
20-abx935623 | Abbexa |
|
|
Rabbit anti-Mus musculus (Mouse) SUFU Polyclonal Antibody |
|||
MBS7142175-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Conduction Band Power-Degree Engineering for Bettering Open-Circuit Voltage in Antimony Selenide Nanorod Array Photo voltaic Cells
Antimony selenide (Sb2 Se3 ) nanorod arrays alongside the [001] orientation are identified to switch photogenerated carriers quickly as a result of strongly anisotropic one-dimensional crystal construction. With superior light-trapping constructions, the Sb2 Se3 nanorod array-based photo voltaic cells have glorious broad spectral response properties, and better short-circuit present density than the traditional planar structured skinny movie photo voltaic cells. Nevertheless, the interface engineering for the Sb2 Se3 nanorod array-based photo voltaic cell is extra essential to extend the efficiency, as a result of it’s difficult to coat a compact buffer layer with good protection to type a uniform heterojunction interface attributable to its massive floor space and length-diameter ratio.
On this work, an intermeshing In2 S3 nanosheet-CdS composite because the buffer layer, compactly coating on the Sb2 Se3 nanorod floor is constructed. The appliance of In2 S3 -CdS composite buffers construct a gradient conduction band power configuration within the Sb2 Se3 /buffer heterojunction interface, which reduces the interface recombination and enhances the switch and assortment of photogenerated electrons. The energy-level regulation minimizes the open-circuit voltage deficit on the interfaces of buffer/Sb2 Se3 and buffer/ZnO layers within the Sb2 Se3 photo voltaic cells. Consequently, the Sb2 Se3 nanorod array photo voltaic cell primarily based on In2 S3 -CdS composite buffers achieves an effectivity of as excessive as 9.19% with a VOC of 461 mV.
Distinguishing between Isomeric Neoxanthin and Violaxanthin Esters in Yellow Flower Petals utilizing Liquid Chromatography-Photodiode Array Atmospheric Stress Chemical Ionization Mass Spectrometry and MS/MS
Rationale: Liquid chromatography-photodiode array atmospheric strain chemical ionization mass spectrometry (LC-PDA-APCI-MS) is used for the evaluation of assorted carotenoid pigments in crops. Amongst them, it’s tough to differentiate between the isomeric violaxanthin/neoxanthin esters.
Strategies: The yellow pigments of tomato petals have been extracted with acetone, and the extracts have been saved at -30°C to settle out the contaminating triacylglycerols bodily. The supernatants have been analyzed utilizing LC-PDA-APCI-MS with a high-resolution orbitrap MS for his or her precise lots. The anticipated carotenoid esters have been calculated with the mixture of carotenoids and fatty acids, they usually have been matched with the experimental precise lots. The fatty acid constructions within the carotenoid esters have been additionally recognized utilizing collision-induced dissociation (CID) MS/MS. The isomeric violaxanthin/neoxanthin esters have been distinguished utilizing CID MS/MS from their in-source dehydrated product ions as pseudoprecursor ions.
Outcomes: The in-source dehydrated ions [M-H2 O+H]+ of neoxanthin diesters predominated over their protonated molecules [M+H]+ within the LC-MS. Against this, the protonated molecules of violaxanthin diesters predominated. The 92 u loss product ions [M-H2 O-C7 H8 +H]+ have been noticed from the dehydrated violaxanthin diesters, however they weren’t generated from the dehydrated neoxanthin diesters within the CID MS/MS of their dehydrated pseudoprecursor ion [M-H2 O+H]+ .
Conclusions: The allene allyl carbocation in neoxanthin diesters was generated from dehydration after preferential protonation on the hydroxy group. The epoxide group of violaxanthin diesters opens simply after protonation; nonetheless, the dehydration didn’t proceed at this stage. The 92 u lack of C7 H8 was defined by the intramolecular [2+2] cycloaddition, which proceeded preferentially in dehydrated violaxanthin diesters as a result of the carbocations within the dehydrated species have been conjugated to the polyene and people double bonds have been depolarized within the CID MS/MS. Due to this fact, the isomeric neoxanthin/violaxanthin diesters have been distinguished utilizing LC-PDA-APCI-MS and MS/MS. This technique was a sensible and helpful technique of profiling the carotenoid esters of the yellow petals.
Beam pen lithography as a brand new software for spatially managed photochemistry, and its utilization within the synthesis of multivalent glycan arrays
Herein, we describe how cantilever-free scanning probes can be utilized to deposit precursor materials and subsequently irradiate the precursor to provoke polymerization, leading to a 3D lithographic technique whereby the place, peak and diameter of every function may be tuned independently. Particularly, acrylate and methacrylate monomers have been patterned onto thiol terminated glass and subsequently uncovered to UV mild produced brush polymers by a photoinduced radical acrylate polymerization response. Right here, we report the primary examples of glycan arrays, comprised of methacrylate brush polymers which are side-chain functionalized with α-glucose, by this new lithographic method.
Their binding with fluorophore labeled concanavalin A (ConA) was assayed by fluorescence microscopy. The fluorescence of those brush polymers was in comparison with glycan arrays composed of monolayers of α-mannosides and α-glucosides ready by combining polymer pen lithography (PPL) with the thiol-ene photochemical response or the copper-catalyzed azide-alkyne cycloaddition. At excessive ConA focus, the fluorescence sign of the brush polymer was practically 20 occasions better than that of the glycan monolayers, and the comb polymer arrays had a detection restrict practically two orders of magnitude higher than their monolayer counterparts.
Due to the potential of this technique to manage exactly the polymer size, the connection between restrict of detection and multivalency could possibly be explored, and it was discovered that the longer polymers (136 nm) are an order of magnitude extra delicate in the direction of ConA binding than the shorter polymers (Eight nm) and that binding affinity decreased systematically with size. These glycan arrays are a brand new software to check the function of multivalency on carbohydrate recognition, and the photopolymerization route in the direction of forming multivalent glycan scaffolds described herein, is a promising path to create multiplexed glycan arrays with nanoscale function dimensions.